PHARMACEUTICAL COMPANY Our expertise Intsel Chimos is a hospital partner strongly involved in early access to innovation and treatment of patients with no therapy available. As a major provider of Early Access Program (EAP) and/or Compassionate Access Program (CAP) ex ATU drugs in France, we bring sustainable solutions to patients with medical needs unmet by available drugs on the French market. Our close contact with numerous international partners allows us to be reactive and flexible at the pace of innovation, even when it comes to products in clinical trials. Intsel Chimos has over 50 years of experience and thus, masters the French health system and its particularities. We strive to support our partners in order to assure them to access the French market in each therapeutic area. This expertise has been built up and confirmed through the numerous pharmaceutical drugs we have made available to hospitals and retail pharmacies. To this end, and as a pharmaceutical company, Intsel Chimos cares about and masters compliance with guidelines such as the Good Manufacturing Practices (GMP), Good Distribution Practices (GDP) and ICH. The management is strongly engaged in and committed to investing in the maintenance of our proactivity through each step of our activities and all along our supply chain. INTSEL CHIMOS Our story Our expertise The group OUR ACTIVITIES EAP/CAP distribution MA exploitant in France Clinical trials distribution PRODUCTS R&D CONTACT REPORT A SIDE EFFECT “This website is intended for French residents and contains information that can refer to health products, the instructions provided by your physician should always be adhered to “ Intsel Chimos, 1 rue Royale, 162 Bureaux de la Colline 92213 SAINT CLOUD cedex, France. Phone number : +33(0)1 49 11 66 80 Contact I Useful links I Legal Notices I Confidentiality Policy © 2018 – LAST UPDATE : 07 / 2021 Axeptio consent